IL6 and neoplasm: designed a CAR-T cell with a non-signaling membrane-bound IL-6 receptor (mbaIL-6) and found that mbaIL-6 expressed on the surface of T cells could rapidly remove IL-6 from the culture serum and circulation in a mouse model without affecting the anti-tumor potential of CAR-T cells (40).